Citi’s Geoff Meacham: Novo misses on Alzheimer’s trial, but ‘winners keep winning’ in obesity drugsNovember 24, 2025
Goldman Sachs says it’s time to start buying the dip, our panel weighs in on bullish outlookNovember 24, 2025
Share Facebook Twitter LinkedIn Pinterest Email Sheila Kahyaoglu, Jefferies defense analyst, joins CNBC’s ‘The Exchange’ to discuss the impact of Iran’s missile strikes on defense stocks, U.S. defense spending, and more.